Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

News provided by

Aug 11, 2011, 04:49 ET

NEW YORK, Aug. 11, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0591463/Interventional-Cardiology-Devices---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_Devices

Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Summary

GlobalData's new report, "Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017" provides key data, information and analysis on the global interventional cardiology devices market. The report provides market landscape, competitive landscape and market trends information on the interventional cardiology devices market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the market's competitive landscape and technology offerings.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.

- Key segments covered include Coronary Stents, PTCA Balloons, Cardiac Catheters, Coronary Guidewires, Arteriotomy Closure Devices, Intravascular Ultrasound Systems and PTCA Coronary Drug Eluting Balloons (DEB).

- Annualized market revenues data from 2003 to 2010, forecast forward for seven years to 2017. Company shares data for 2010.

- Qualitative analysis of key market trends, market drivers, and restraints by each category within the interventional cardiology devices market.

- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.

- Key players covered include Boston Scientific Corporation, Abbott Laboratories, Medtronic, Cordis Corporation and Terumo Corporation.

Reasons to buy

- Develop business strategies by understanding the trends and developments that are driving the interventional cardiology devices market globally.

- Design and develop your product development, marketing and sales strategies.

- Develop market-entry and market expansion strategies.

- Identify key players best positioned to take advantage of the emerging market opportunities.

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.

- What's the next big thing in the interventional cardiology devices market landscape? – Identify, understand and capitalize.Make more informed business decisions from the insightful and in-depth analysis of the global interventional cardiology devices market and the factors shaping it.

Table of Contents

1 Table of Contents

1 Table of Contents 3

1.1 List of Tables 6

1.2 List of Figures 8

2 Introduction 10

2.1 GlobalData Report Guidance 10

3 Disease Overview - Coronary Heart Disease (CHD) 11

3.1 Introduction 11

3.2 Etiology 11

3.3 Pathophysiology 11

3.4 Symptoms 11

3.5 Risk Factors 12

3.6 Epidemiology 12

3.6.1 Prevalence of Coronary Heart Disease (CHD) in the US 12

3.6.2 Prevalence of Coronary Heart Disease (CHD) in Europe 12

4 Interventional Cardiology Devices - Overview 13

4.1 Arteriotomy Closure Devices 13

4.2 Cardiac Catheters 13

4.2.1 Angiography Catheters 13

4.2.2 Guiding Catheters 14

4.3 PTCA Coronary Drug Eluting Balloons (DEB) 14

4.4 Coronary Guidewires 14

4.5 Coronary Stents 14

4.5.1 Bare Metal Stents (BMS) 14

4.5.2 Drug Eluting Stents (DES) 15

4.6 Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons 15

4.6.1 FW Balloons 15

4.6.2 Over the Wire Balloons 15

4.6.3 Rapid Exchange Balloons 15

4.6.4 PTCA Cutting and Scoring Balloons 15

4.7 Intravascular Ultrasound Systems (IVUS) 15

4.7.1 Intravascular Ultrasound Catheter 15

4.7.2 Intravascular Ultrasound System Console 15

5 Interventional Cardiology Devices: Market Characterization 16

5.1 Interventional Cardiology Devices Market, Global, Revenue ($bn), Historic, 2003–2010 16

5.2 Interventional Cardiology Devices Market, Global, Revenue ($bn), Forecast, 2010–2017 17

5.3 Interventional Cardiology Devices Market, Key Trends 18

5.3.1 Transradial Intervention Promises Robust Growth of Percutaneous Coronary Intervention Procedures in the Future 18

5.3.2 The Market is Witnessing an Increasing Shift towards Percutaneous Coronary Intervention (PCI) Procedures Compared to Coronary Artery Bypass Graft Procedures 19

5.3.3 Decrease in Mortality Rate Associated with Coronary Heart Disease (CHD) due to Adoption of PCI Procedures has Increased Physicians' Confidence 21

5.3.4 Reducing Price Trend in the Coronary Stents Market to Continue due to Intense Competition between New Entrants and Existing Companies 22

5.4 Interventional Cardiology Devices, Market Dynamics 24

5.4.1 Market Drivers 25

5.4.2 Market Restraints 31

6 Interventional Cardiology Devices Market: Segment Analysis 35

6.1 Coronary Stents Market, Global, Revenue ($bn), Historic, 2003–2010 35

6.2 Coronary Stents Market, Global, Revenue ($m), Forecast, 2010-–2017 36

6.3 PTCA Balloons Market, Global, Revenue ($m), Historic, 2003–2010 37

6.4 PTCA Balloons Market, Global, Revenue ($m), Forecast, 2010—2017 38

6.5 Cardiac Catheters Market, Global, Revenue ($m), Historic, 2003–2010 39

6.6 Cardiac Catheters Market, Global, Revenue ($m), Forecast, 2010-–2017 40

6.7 Coronary Guidewires Market, Global, Revenue ($m), Historic, 2003–2010 41

6.8 Coronary Guidewires Market, Global, Revenue ($m), Forecast, 2010-–2017 42

6.9 Arteriotomy Closure Devices Market, Global, Revenue ($m), Historic, 2003–2010 43

6.10 Arteriotomy Closure Devices Market, Global, Revenue ($m), Forecast, 2010-–2017 44

6.11 Intravascular Ultrasound Systems Market, Global, Revenue ($m), Historic, 2003–2010 45

6.12 Intravascular Ultrasound Systems Market, Global, Revenue ($m), Forecasts, 2010-–2017 46

6.13 PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), Historic, 2003–2010 47

6.14 PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), Forecasts, 2010-–2017 48

7 Interventional Cardiology Devices Market, Revenue ($m), by Country, Revenue ($m), 2003–2017 49

7.1 Interventional Cardiology Devices Market, US, Revenue ($m), Historic, 2003–2010 49

7.2 Interventional Cardiology Devices Market, US, Revenue ($m), Forecast, 2010–2017 50

7.3 Interventional Cardiology Devices Market, Canada, Revenue ($m), Historic, 2003–2010 52

7.4 Interventional Cardiology Devices Market, Canada, Revenue ($m), Forecast, 2010–2017 53

7.5 Interventional Cardiology Devices Market, UK, Revenue ($m), Historic, 2003–2010 55

7.6 Interventional Cardiology Devices Market, UK, Revenue ($m), Forecast, 2010–2017 56

7.7 Interventional Cardiology Devices Market, France, Revenue ($m), Historic, 2003–2010 58

7.8 Interventional Cardiology Devices Market, France, Revenue ($m), Forecast, 2010–2017 59

7.9 Interventional Cardiology Devices Market, Germany, Revenue ($m), Historic, 2003–2010 61

7.10 Interventional Cardiology Devices Market, Germany, Revenue ($m), Forecast, 2010–2017 62

7.11 Interventional Cardiology Devices Market, Italy, Revenue ($m), Historic, 2003–2010 64

7.12 Interventional Cardiology Devices Market, Italy, Revenue ($m), Forecast, 2010–2017 65

7.13 Interventional Cardiology Devices Market, Spain, Revenue ($m), Historic, 2003–2010 67

7.14 Interventional Cardiology Devices Market, Spain, Revenue ($m), Forecast, 2010–2017 68

7.15 Interventional Cardiology Devices Market, Japan, Revenue ($m), Historic, 2003–2010 70

7.16 Interventional Cardiology Devices Market, Japan, Revenue ($m), Forecast, 2010–2017 71

7.17 Interventional Cardiology Devices Market, China, Revenue ($m), Historic, 2003–2010 72

7.18 Interventional Cardiology Devices Market, China, Revenue ($m), Forecast, 2010–2017 74

7.19 Interventional Cardiology Devices Market, Australia, Revenue ($m), Historic, 2003–2010 75

7.20 Interventional Cardiology Devices Market, Australia, Revenue ($m), Forecast, 2010–2017 77

7.21 Interventional Cardiology Devices Market, India, Revenue ($m), Historic, 2003–2010 78

7.22 Interventional Cardiology Devices Market, India, Revenue ($m), Forecast, 2010–2017 80

7.23 Interventional Cardiology Devices Market, Brazil, Revenue ($m), Historic, 2003–2010 81

7.24 Interventional Cardiology Devices Market, Brazil, Revenue ($m), Forecast, 2010–2017 83

8 Interventional Cardiology Devices Market: Strategic Competitive Assessment 85

8.1 Interventional Cardiology Devices Market, Global, Company Share (%), 2010 85

8.2 Interventional Cardiology Devices, Market Opportunities and Risk Evaluation 86

8.3 Boston Scientific Corporation 87

8.3.1 Key Marketed Products 87

8.3.2 Boston Scientific Corporation, Internal Factors Analysis 88

8.4 Abbott Laboratories 89

8.4.1 Key Marketed Products 89

8.4.2 Abbott Laboratories, Internal Factors Analysis 90

8.5 Medtronic, Inc. 91

8.5.1 Key Marketed Products 91

8.5.2 Medtronic, Internal Factors Analysis 91

8.6 Cordis Corporation 93

8.6.2 Key Marketed Products 93

8.6.3 Cordis Corporation, Internal Factors Analysis 94

8.7 Terumo Corporation 95

8.7.2 Key Marketed Products 95

8.7.3 Terumo Corporation, Internal Factors Analysis 96

9 Global Interventional Cardiology Devices: Strategic Pipeline Assessment 97

9.1 Interventional Cardiology Devices: Pipeline Products Summary 97

9.2 Bioabsorbable Stents, List of Pipeline Products 98

9.2.1 Bioabsorbable Stents, Pipeline Assessment, by Development Stage 99

9.2.2 Bioabsorbable Stents, Pipeline Assessment, by Unmet Need 100

9.2.3 Bioabsorbable Stents Market, Key Pipeline Products 101

Drug Eluting Absorbable Metal Scaffold 102

9.3 PTCA Coronary Drug Eluting Balloons (DEB) 104

9.3.1 PTCA Coronary Drug Eluting Balloons Market, Key Pipeline Products 104

9.4 Drug Eluting Stents, List of Pipeline Products 106

9.4.1 Drug Eluting Stents Market, Key Pipeline Products 109

9.5 Bare Metal Stents, List of Pipeline Products 118

9.6 Bifurcation Stents, List of Pipeline Products 119

9.6.1 Bifurcation Stents Market, Key Pipeline Products 120

9.7 PTCA Balloons 121

9.7.1 PTCA Balloons Market, Key Pipeline Products 122

9.8 Cardiac Catheters 123

9.8.1 Cardiac Catheters Market, Key Pipeline Products 124

9.9 Coronary Guidewires 125

9.9.1 Coronary Guidewires Market, Key Pipeline Products 126

9.10 Intravascular Ultrasound Systems (IVUS) 126

9.11 Arteriotomy Closure Devices 127

9.11.1 Arteriotomy Closure Devices Market, Key Pipeline Products 127

9.12 Other Interventional Cardiology Devices 130

10 Interventional Cardiology Devices Market: M&A Landscape 132

10.1 Key Acquisitions 132

10.1.1 Biosensors International Acquires CardioMind 132

10.1.2 Opto Circuits Completes Acquisition of N.S. Remedies 132

10.1.3 Medtronic Completes Acquisition of Invatec and Affiliated Companies 132

10.1.4 Boston Scientific Acquires Labcoat 133

10.1.5 St. Jude Medical Acquires Stake in Micell Technologies 133

10.1.6 Lake Region Medical Acquires Brivant Medical 134

10.1.7 Biosensors International Group Acquires Remaining 50% Interest in JW Medical Systems 134

10.1.8 Royal DSM Acquires The Polymer Technology Group 135

11 Appendix 136

11.1 Definitions 137

11.1.1 Interventional Cardiology 137

11.1.2 Arteriotomy Closure Devices 137

11.1.3 Cardiac Catheters 137

11.1.4 Coronary Guidewires 137

11.1.5 Coronary Stents 137

11.1.6 PTCA Balloons 138

11.1.7 PTCA Coronary Drug Eluting Balloons (DEB) 138

11.2 Acronyms 139

11.3 Sources 140

11.4 Research Methodology 141

11.4.1 Secondary Research 141

11.4.2 Primary Research 141

11.4.3 Models 142

11.4.4 Forecasts 142

11.4.5 Expert Panel 142

11.5 GlobalData Consulting 142

11.6 Contact Us 142

11.7 Disclaimer 143

List of Tables

1.1 List of Tables

Table 1: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2003–2010 16

Table 2: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2010–2017 17

Table 3: Percutaneous Coronary Intervention (PCI) Procedures vs. Coronary Artery Bypass Graft (CABG) Procedures (millions), Global, 2007-2010 19

Table 4: Age-Adjusted Coronary Heart Disease (CHD) Mortality Rate (per 100,000), The US, 2000–2007 21

Table 5: Coronary Stents Market, Average Selling Price ($), The US, 2003–2010 22

Table 6: Drug Eluting Stents Market, List of Key Clinical Trials 26

Table 7: Cardiac Catheterization Procedures (millions), The US, 2006–2010 30

Table 8: Intravascular Ultrasound Systems Market, Average Selling Price ($), Developed Countries, 2010 33

Table 9: Coronary Stents Market, Global, Revenue ($bn), 2003–2010 35

Table 10: Coronary Stents Market, Global, Revenue ($bn), 2010–2017 36

Table 11: PTCA Balloons Market, Global, Revenue ($m), 2003–2010 37

Table 12: PTCA Balloons Market, Global, Revenue ($m), 2010–2017 38

Table 13: Cardiac Catheters Market, Global, Revenue ($m), 2003–2010 39

Table 14: Cardiac Catheters Market, Global, Revenue ($m), 2010–2017 40

Table 15: Coronary Guidewires Market, Global, Revenue ($m), 2003–2010 41

Table 16: Coronary Guidewires Market, Global, Revenue ($m), 2010–2017 42

Table 17: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2003–2010 43

Table 18: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2010–2017 44

Table 19: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2003–2010 45

Table 20: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2010–2017 46

Table 21: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2003–2010 47

Table 22: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2010–2017 48

Table 23: Interventional Cardiology Devices Market, US, Revenue ($m), 2003–2010 49

Table 24: Interventional Cardiology Devices Market, US, Revenue ($m), 2010–2017 51

Table 25: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2003–2010 52

Table 26: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2010–2017 54

Table 27: Interventional Cardiology Devices Market, UK, Revenue ($m), 2003–2010 55

Table 28: Interventional Cardiology Devices Market, UK, Revenue ($m), 2010–2017 57

Table 29: Interventional Cardiology Devices Market, France, Revenue ($m), 2003–2010 58

Table 30: Interventional Cardiology Devices Market, France, Revenue ($m), 2010–2017 60

Table 31: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2003–2010 61

Table 32: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2010–2017 63

Table 33: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2003–2010 64

Table 34: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2010–2017 66

Table 35: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2003–2010 67

Table 36: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2010–2017 69

Table 37: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2003–2010 70

Table 38: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2010–2017 71

Table 39: Interventional Cardiology Devices Market, China, Revenue ($m), 2003–2010 73

Table 40: Interventional Cardiology Devices Market, China, Revenue ($m), 2010–2017 74

Table 41: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2003–2010 76

Table 42: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2010–2017 77

Table 43: Interventional Cardiology Devices Market, India, Revenue ($m), 2003–2010 79

Table 44: Interventional Cardiology Devices Market, India, Revenue ($m), 2010–2017 80

Table 45: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2003–2010 82

Table 46: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2010–2017 83

Table 47: Interventional Cardiology Devices Market, Global, Company Share (%), Revenue ($m), 2010 85

Table 48: Boston Scientific Corporation, Marketed Products, Product Type, Features and Benefits, 2011 87

Table 49: Abbott Laboratories, Key Marketed Products, Product Type, Features and Benefits, 2011 89

Table 50: Medtronic, Inc., Key Marketed Products, Product Type, Features and Benefits, 2011 91

Table 51: Cordis Corporation, Key Marketed Products, Product Type, Features and Benefits, 2011 93

Table 52: Terumo Corporation, Key Marketed Products, Product Type, Features and Benefits, 2011 95

Table 53: Interventional Cardiology Devices, Pipeline Products Summary, 2011 97

Table 54: Bioabsorbable Stents Market, List of Pipeline Products, Global, 2011 98

Table 55: Absorb, Product Status 101

Table 56: Drug Eluting Absorbable Metal Scaffold, Product Status 102

Table 57: Myolimus Eluting Coronary Stents-Bioabsorbable Polymer - Product Status 102

Table 58: PTCA Coronary Drug Eluting Balloons (DEB) Market, List of Pipeline Products, Global, 2011 104

Table 59: SeQuent Please, Product Status 104

Table 60: Next Generation Rapamycin (Sirolimus)-Based DEB, Product Status 105

Table 61: DIOR Paclitaxel-Eluting Coronary Balloon Catheter, Product Status 105

Table 62: Drug Eluting Stents, List of Pipeline Products, Global, 2011 106

Table 63: BioFreedom, Product Status 109

Table 64: BioMatrix Drug Eluting Stent, Product Status 109

Table 65: CYPHER Sirolimus-eluting Coronary Stents – AMI, Product Status 110

Table 66: DESyne BD Novolimus Eluting Coronary Stents System – Product Status 111

Table 67: Endeavor Resolute – Product Status 112

Table 68: Genius TAXCOR I – Product Status 113

Table 69: Infinnium Paclitaxel Eluting Coronary Stents System – Product Status 115

Table 70: MAHOROBA Stent – Product Status 116

Table 71: Bare Metal Stents Market, List of Pipeline Products, Global, 2011 118

Table 72: Bifurcation Stents Market, List of Pipeline Products, Global, 2011 119

Table 73: AXXESS Biolimus A9 Eluting Bifurcation Stent System, Product Status 120

Table 74: PTCA Balloons Market, List of Pipeline Products, Global, 2011 121

Table 75: Zylon Zero-Fold Angioplasty Balloon Catheter – Product Status 122

Table 76: Avion Bifurcation RX2 - Product Status 122

Table 77: Cardiac Catheters Market, List of Pipeline Products, Global, 2011 123

Table 78: Stingray CTO Re-Entry System – Product Status 124

Table 79: MyoCath – Product Status 124

Table 80: Genie Catheter – Product Status 124

Table 81: Diamondback 360°-Calcified Coronary Lesions – Product Status 125

Table 82: Coronary Guidewires Market, List of Pipeline Products, Global, 2011 125

Table 83: Wrist Artery Guidewire – Product Status 126

Table 84: Intravascular Ultrasound Systems (IVUS) Market, List of Pipeline Products, Global, 2011 126

Table 85: Arteriotomy Closure Devices Market, List of Pipeline Products, Global, 2011 127

Table 86: EpiClose Plus – Product Status 127

Table 87: ExoSeal Vascular Closure Device – Product Status 128

Table 88: Second Generation CloSys Hemostasis Device – Product Status 128

Table 89: FastSeal Bioabsorbable Vascular Access Closure System – Product Status 129

Table 90: Other Interventional Cardiology Devices Market, List of Pipeline Products, Global, 2010 130

Table 91: Biosensors International Acquires CardioMind, 2010 132

Table 92: Opto Circuits Completes Acquisition of N.S. Remedies, 2010 132

Table 93: Medtronic Completes Acquisition of Invatec and Affiliated Companies, 2010 132

Table 94: Boston Scientific Acquires Labcoat, 2009 133

Table 95: St. Jude Medical Acquires Stake In Micell Technologies, 2008 133

Table 96: Lake Region Medical Acquires Brivant Medical, 2008 134

Table 97: Biosensors International Group Acquires Remaining 50% Interest In JW Medical Systems, 2008 134

Table 98: Royal DSM Acquires The Polymer Technology Group, 2008 135

List of Figures

1.2 List of Figures

Figure 1: Interventional Cardiology Devices, Market Segmentation 13

Figure 2: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2003–2010 16

Figure 3: Interventional Cardiology Devices Market, Global, Revenue ($bn), 2010–2017 17

Figure 4: Interventional Cardiology Devices Market, Transradial Intervention Vs. Femoral Access Intervention 18

Figure 5: Percutaneous Coronary Intervention (PCI) Procedures vs. Coronary Artery Bypass Graft (CABG) Procedures, Global, 2007-2010 19

Figure 6: Age-Adjusted Coronary Heart Disease (CHD) Mortality Rate (per 100,000), The US, 2000–2007 21

Figure 7: Coronary Stents Market, Average Selling Price ($), The US, 2003–2010 22

Figure 8: Interventional Cardiology Devices, Market Dynamics 24

Figure 9: Bioabsorbable Stents Vs Drug Eluting Stents (DES), Technology Benchmarking 25

Figure 10: PTCA Coronary Drug Eluting Balloons (DEB) Vs Drug Eluting Stents (DES), Technology Benchmarking 27

Figure 11: Cardiac Catheterization Procedures (millions), The US, 2006–2010 30

Figure 12: Coronary Stents Market, Global, Revenue ($bn), 2003–2010 35

Figure 13: Coronary Stents Market, Global, Revenue ($bn), 2010–2017 36

Figure 14: PTCA Balloons Market, Global, Revenue ($m), 2003–2010 37

Figure 15: PTCA Balloons Market, Global, Revenue ($m), 2010–2017 38

Figure 16: Cardiac Catheters Market, Global, Revenue ($m), 2003–2010 39

Figure 17: Cardiac Catheters Market, Global, Revenue ($m), 2010–2017 40

Figure 18: Coronary Guidewires Market, Global, Revenue ($m), 2003–2010 41

Figure 19: Coronary Guidewires Market, Global, Revenue ($m), 2010–2017 42

Figure 20: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2003–2010 43

Figure 21: Arteriotomy Closure Devices Market, Global, Revenue ($m), 2010–2017 44

Figure 22: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2003–2010 45

Figure 23: Intravascular Ultrasound Systems Market, Global, Revenue ($m), 2010–2017 46

Figure 24: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2003–2010 47

Figure 25: PTCA Coronary Drug Eluting Balloons (DEB) Market, Global, Revenue ($m), 2010-2017 48

Figure 26: Interventional Cardiology Devices Market, US, Revenue ($m), 2003–2010 49

Figure 27: Interventional Cardiology Devices Market, US, Revenue ($m), 2010–2017 50

Figure 28: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2003–2010 52

Figure 29: Interventional Cardiology Devices Market, Canada, Revenue ($m), 2010–2017 53

Figure 30: Interventional Cardiology Devices Market, UK, Revenue ($m), 2003–2010 55

Figure 31: Interventional Cardiology Devices Market, UK, Revenue ($m), 2010–2017 56

Figure 32: Interventional Cardiology Devices Market, France, Revenue ($m), 2003–2010 58

Figure 33: Interventional Cardiology Devices Market, France, Revenue ($m), 2010–2017 59

Figure 34: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2003–2010 61

Figure 35: Interventional Cardiology Devices Market, Germany, Revenue ($m), 2010–2017 62

Figure 36: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2003–2010 64

Figure 37: Interventional Cardiology Devices Market, Italy, Revenue ($m), 2010–2017 65

Figure 38: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2003–2010 67

Figure 39: Interventional Cardiology Devices Market, Spain, Revenue ($m), 2010–2017 68

Figure 40: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2003–2010 70

Figure 41: Interventional Cardiology Devices Market, Japan, Revenue ($m), 2010–2017 71

Figure 42: Interventional Cardiology Devices Market, China, Revenue ($m), 2003–2010 72

Figure 43: Interventional Cardiology Devices Market, China, Revenue ($m), 2010–2017 74

Figure 44: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2003–2010 75

Figure 45: Interventional Cardiology Devices Market, Australia, Revenue ($m), 2010–2017 77

Figure 46: Interventional Cardiology Devices Market, India, Revenue ($m), 2003–2010 78

Figure 47: Interventional Cardiology Devices Market, India, Revenue ($m), 2010–2017 80

Figure 48: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2003–2010 81

Figure 49: Interventional Cardiology Devices Market, Brazil, Revenue ($m), 2010–2017 83

Figure 50: Interventional Cardiology Devices Market, Global, Company Share (%) , 2010 85

Figure 51: Interventional Cardiology Devices, Market Opportunities and Risk Evaluation 86

Figure 52: Boston Scientific Corporation, Internal Factors Analysis 88

Figure 53: Abbott Laboratories, Internal Factors Analysis 90

Figure 54: Medtronic, Inc., Internal Factors Analysis 91

Figure 55: Cordis Corporation, Internal Factors Analysis 94

Figure 56: Terumo Corporation, Internal Factors Analysis 96

Figure 57: Interventional Cardiology Devices, Pipeline Products Summary, 2011 97

Figure 58: Bioabsorbable Stents Market, Pipeline Assessment, by Development Stage 99

Figure 59: Bioabsorbable Stents Market, Pipeline Assessment, by Unmet Need 100

Figure 60: Comparison of In Vivo Acute Stent Recoil Between The Bioabsorbable Everolimus-Eluting Coronary Stents And The Everolimus-eluting Cobalt Chromium Coronary Stents: Insights From The ABSORB And SPIRIT Trials 101

Figure 61: Myolimus Eluting Coronary Stents-Bioabsorbable Polymer – First-In-Man Study Of The Myolimus Eluting Coronary Stents System 103

Figure 62: Paclitaxel-eluting Balloon Versus Paclitaxel-eluting Stent In Small Coronary Vessel Disease 106

Figure 63: CYPHER Sirolimus-eluting Coronary Stents – AMI – Use Of The Cypher Sirolimus-Eluting Coronary Stents In Acute Myocardial Infarction Treated With Balloon Angioplasty 110

Figure 64: DESyne BD Novolimus Eluting Coronary Stents System – Novolimus Eluting Coronary Stents System with Bioabsorbable Polymer: Nine-Month Clinical and Six-Month Angiographic Results 111

Figure 65: Endeavor Resolute - The Clinical Response Evaluation Of The Medtronic Endeavor CR ABT-578 Eluting Coronary Stents System In De Novo Native Coronary Artery Lesions 113

Figure 66: Genius TAXCOR I – Evaluating The Efficiency Of Genius TAXCOR In A Multi-Center Clinical Trial Study 114

Figure 67: Infinnium Paclitaxel Eluting Coronary Stents System – Safety And Efficacy Of The Infinnium Paclitaxel Eluting Stent In Single De Novo Native Coronary Artery Lesions 115

Figure 68: Infinnium Paclitaxel Eluting Coronary Stents System – Safety And Efficacy Of Infinnium Stent In The Patients With CAD In More Then One Vessel 116

Figure 69: MAHOROBA Stent – First-In-Man Study Using The Tacrolimus-Eluting Bioabsorbable Polymer-Coated Cobalt–Chromium MAHOROBA Stent 117

Companies Mentioned

Boston Scientific Corporation

Abbott Laboratories

Medtronic, Inc.

Cordis Corporation

Terumo Corporation

To order this report:

Cardiovascular Devices Industry: Interventional Cardiology Devices - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

Cardiovascular Devices Business News

More Market Research Report

Check our Company Profile, SWOT and Revenue Analysis!